ARCHIVES

Banned Investigator Plans To Resume Clinical Trials Role

This article is from The Cancer Letter archive.

Vol. 16 No. 32 | August 10, 1990

Download PDF Visit The Full Archive

Related Articles

DCPC Bard Approves $10 Million In Concepts

October 2, 1987

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995

NCI Cooperative Group, Cancer Center Trials Listed

November 28, 2008

It’s Official – UCLA Recognize As 19th Comprehensive Center

January 7, 1977

In Brief: Healy Names President, CEO of Red Cross; AMA Supports annual Mammograms for 40+

July 16, 1999

In Brief: CT Scanning Reduced Morbidity, Mortality, Helps Deliver Optimal Treatment, Consensus Panel Says

November 27, 1981